EGFR and interstitial lung disease: We conducted this study to obtain useful information regarding the benefits and drawbacks of EGFR-TKI re-administration by evaluating the efficacy and adverse events of EGFR-TKI re-administration in patients after recovery from EGFR-TKI-induced ILD.